Kevin Cassidy
VP
Biopharmaceuticals
Microbix Biosystems
Canada
Biography
Kevin is responsible for Microbix’ Kinlytic brand biopharmaceutical product used for treatment of pulmonary embolism and biomedical catheter management. He has a BSc and over 30 years of experience in the biotech and healthcare industries. He is credited with development of the Company’s leading antigen products and establishment of GMP operations in Canada, China and Chile. In his tenure at Microbix Mr. Cassidy has held numerous roles including heading up company diagnostic product operations.
Research Interest
biotech and healthcare industries.company diagnostic product operations.
